Back
Lithia Motors 10K Form
Buy
55
LAD
Lithia Motors
Last Price:
368.20
Seasonality Move:
9.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | LAD/Lithia Motors Quarterly |
2023-10-27 | 10Q | LAD/Lithia Motors Quarterly |
2023-08-04 | 10Q | LAD/Lithia Motors Quarterly |
2023-04-28 | 10Q | LAD/Lithia Motors Quarterly |
2022-10-27 | 10Q | LAD/Lithia Motors Quarterly |
2022-07-28 | 10Q | LAD/Lithia Motors Quarterly |
Receive LAD News And Ratings
See the #1 stock for the next 7 days that we like better than LAD
LAD Financial Statistics
Sales & Book Value
Annual Sales: | $31.04B |
---|---|
Cash Flow: | $157.1M |
Price / Cash Flow: | 0 |
Annual Sales: | $247.00 |
Price / Book: | 1.42 |
Profitability
EPS (TTM): | 29.30000 |
---|---|
Net Income (TTM): | $799.4M |
Gross Margin: | $5.23B |
Return on Equity: | 12.55% |
Return on Assets: | 3.75% |
Lithia Motors Earnings Forecast
Key Lithia Motors Financial Ratios
- The Gross Profit Margin over the past 29 years for LAD is 16.84%.
- The Selling, General & Administrative Expenses for LAD have been equal to 10.72% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 35.18% of Operating Income.
- The Net Earning history of LAD is 3.22% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 23 years.
Lithia Motors Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Specialty Retail |
Sector: | Consumer Discretionary |
Current Symbol: | LAD |
CUSIP: | 536797 |
Website: | lithia.com |
Debt
Debt-to-Equity Ratio: | 2.03 |
---|---|
Current Ratio: | 1.18 |
Quick Ratio: | 0.24 |
Price-to-Earnings
Trailing P/E Ratio: | 9.66 |
---|---|
Forward P/E Ratio: | 10.03 |
LAD Technical Analysis vs Fundamental Analysis
Buy
55
Lithia Motors (LAD)
is a Buy
Is Lithia Motors a Buy or a Sell?
-
Lithia Motors stock is rated a Buy
The current Lithia Motors [LAD] share price is $350.67. The Score for LAD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.